First Class of Honorees Inducted Into New Cancer Hall of Fame
Published June 2008
There is a group of everyday heroes among us whose mission is to beat an awful disease that 1.4 million Americans are diagnosed with each year—cancer.
Some fight daily battles with their patients against cancer.
Others spend hours behind a lab bench, tirelessly analyzing cells and compounds to understand biological mechanisms so they can develope new ways to combat cancer and improve the lives of those living with it.
Others travel throughout the community, spreading the important message of early cancer detection and prevention to high-risk populations or generating funding to support research that will improve cancer treatment options.
It’s these individual efforts that add up to make a major impact in the fight against cancer.
Five of these “heroes” were recently recognized as part of the newly formed UC Cancer Hall of Fame. This honor was created to recognize individuals who have made a difference in the lives of people with cancer in Greater Cincinnati.
Herschel Chalk, Paul Flory, Jack Gluckman, MD, and Beatrice Lampkin, MD, were recognized for their efforts in combating cancer and improving the outcome for people with the disease at a May 9 event at the Cincinnati Country Club. Bernard Aron, MD, was recognized at an event on June 1.
For Lampkin, UC professor emeritus of pediatrics and oncologist at Cincinnati Children’s Hospital Medical Center, battling—and beating—childhood cancers has been the driving force in her life.
In her distinguished career of more than 30 years, she has accomplished many important things that have changed the outcome for thousands of children across Greater Cincinnati and the world.
Her laboratory and translational research on the effect of drugs on the cell cycle of acute myeloid leukemia led to development of new drugs that would “cure” the disease. In addition, she founded the pediatric bone marrow transplant program in 1981 and established the long-term survivor clinic in 1988.
“Dr. Lampkin illustrates the best of the so-called triple threat—a tireless researcher, a caring doctor and dedicated educator,” says colleague Ralph Gruppo, MD, professor of clinical pediatrics at UC and oncologist at Cincinnati Children’s.
“She recognized the importance of involving a multidisciplinary team of physicians to provide the best care of treating children treating cancer,” he says. “She also recognized that care of children with cancer did not end once they were cured, and she founded the long-term survivor’s clinic to help manage and minimize the side effects of cancer treatment.”
When asked what she enjoyed most about her career, though, Lampkin says it was teaching.
She had a hand in training more than 80 oncologists and researchers who are now practicing across the country. Although she retired in 1991, she still actively engages in teaching pediatric residents and fellows at Cincinnati Children’s.
“I’m highly honored and humbled by this honor, but it isn’t just for me,” she says. “It’s for all the people who work so hard in the division and for the children and families who participated in research of investigational drugs we used in the early days.”